Reporting Manager
Trails Edge Capital Partners, LP
Symbol
XFOR
Shares outstanding
90,124,517 shares
Disclosed Ownership
5,227,222 shares
Ownership
5.8%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:30:12 UTC
Date of event
31 Dec 2025
Previous filing
18 Aug 2025

Sponsored

Quoteable Key Fact

"Trails Edge Capital Partners, LP disclosed 5.8% ownership in X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR) on 31 Dec 2025."

Quick Takeaways

  • Trails Edge Capital Partners, LP filed SCHEDULE 13G/A for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR).
  • Disclosed ownership: 5.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 18 Aug 2025.
  • Current filing was accepted on 17 Feb 2026, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 5.8% 5,227,222 5,227,222 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 5.8% 5,227,222 5,227,222 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 5.8% 5,227,222 5,227,222 0 /s/ Ortav Yehudai Ortav Yehudai / Individual